The use of an immunosuppressive therapy known as tocilizumab, approved to treat the indication of rheumatoid arthritis, has been tested […]
Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to […]
TrialSite has reported on a few different study results indicating that Roche’s Actemra (tocilizumab), an IL-6 inhibitor, doesn’t help to lower […]
Some patients’ immune systems have responded to SARS-CoV-2 infections by going into a form of overdrive, leading to the overzealous […]
Valley Baptist Medical Center-Harlingen, based in the Rio Grande Valley in Texas, was selected to participate in a clinical trial […]
TrialSite recently suggested based on unfolding study results that repurposed IL-6 inhibitors, such as Roche’s Actemra®/ReActemtra® (tocilizumab), may not work to […]
200 mg vial Tocilizumab—15,000 Rs ($200.20)
400 mg vial Tocilizumab—30,000 Rs ($400.39)
Full Itolizumab Treatment—40,000 rupees
Baylor College of Medicine is a clinical investigational site for a clinical trial investigating the therapeutic benefits of an immunomodulator […]
Genentech (Roche) plans a Phase III clinical trial to assess its marketed drug Actemra (tocilizumab) as a treatment for severe […]
